Executive appointments at Merck & Co, Actelion and Jazz Pharma – The Pharma Letter



Citybizlist
Executive appointments at Merck & Co, Actelion and Jazz Pharma
The Pharma Letter
US drug giant Merck & Co (NYSE: MRK) has appointed Cuong Viet Do as chief strategy officer, effective October 3. In this position he will be responsible for both developing and executing enterprise-wide strategy and further building connections between
Merck goes outside drug industry for strategy exec, (NYSE: MRK), (NYSE: TEL)Takeover Chatter

all 29 news articles »

Pharmaceuticals – Google News